Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content
Fig. 3 | Cellular & Molecular Biology Letters

Fig. 3

From: CDC20 protects the heart from doxorubicin-induced cardiotoxicity by modulating CCDC69 degradation

Fig. 3

Overexpression of CDC20 attenuates DOX-induced cardiac dysfunction, fibrosis, and apoptosis. a Survival curve of mice in each group: b EF% statistics of mice in each group (n = 6–13); c HW/TL statistics of mice in each group (n = 6–13); d Representative image of Masson staining in each group (n = 6–13, bar = 100 μm); e Representative image and statistics of WGA staining in each group (n = 6–13, bar = 50 μm); f HE staining image in each group (n = 6–13, bar = 40 μm); g Representative image and statistical data of vacuolization in each group (n = 6–13, bar = 40 μm); h Representative image and statistical data of TUNEL staining in group (n = 6–13, bar = 40 μm); i Detected expression of Bax, Bcl-2, and β-actin using western blotting (n = 4). DOX: doxorubicin, EF: ejection factor, H&E: Hematoxylin and eosin, HW/TL: heart weight/tibia length, TUNEL: terminal deoxynucleotidyl transferase dUTP nick end labeling, WGA: wheat germ agglutinin. Data presented as mean ± SD. Statistical analysis performed with two-way ANOVA

Back to article page